Responsiveness is the ability to detect change over time and is an important aspect of measures used to detect treatment effects. The purpose of this study was to assess the responsiveness of the HOOS JR, the KOOS JR, and the PROMIS Physical Function (PF) computerized adaptive test (CAT) in a joint reconstruction practice. 983 patients were evaluated for joint conditions between 2014 and 2017 in an orthopaedic clinic and completed the three instruments at baseline and 3 and/or 6-month follow-up visits. Average age was 61.03 years (SD ¼ 12.33, Range ¼ 18-90 years) and the majority of the patients were White (n ¼ 875, 89.0%). Three-month responsiveness was calculated two ways, as between 80 and 100 days and as 90 days and beyond. Six-month responsiveness was calculated as 170-190 days and as 180 days and beyond. All changes from baseline scores were significant at the 3-, >3-, and >6-month follow-up (p < 0.05). All three measures showed large effect sizes, ranging from 0.80-1.20 at each time-point. The standardized response mean was large for each measure and at each time-point (Range ¼ 1.06-1.53 ). This study demonstrated the responsiveness of the HOOS JR, KOOS JR, and the PROMIS PF in adult reconstruction patients. The PROMIS PF was consistently the most responsive instrument in this analysis. Clinical significance: The HOOS JR, KOOS JR, and PROMIS PF are useful clinical instruments for assessing treatment change and may be selected as relevant to the specific needs and conditions of the adult joint reconstruction patient population. ß
The importance of the patient perspective in evaluating treatment effectiveness cannot be overstated. The patient perspective sits at the heart of patient-centered care and plays a central role in recent efforts to improve healthcare quality. 1 The use of patient reported outcome measures (PRO)s has been incorporated into the Centers for Medicaid and Medicare Services (CMS) comprehensive care for joint replacement model precisely because of the importance of patient feedback in evaluating treatment effectiveness. 2 Hip and knee replacements are the most common inpatient surgeries for Medicare beneficiaries and cost over $7 billion in CMS funded hospitalizations in 2014. 2 Despite endorsement in funding models by CMS and the recommendation of health care quality initiatives, PROs have not been fully implemented into clinical practice settings. 3 The recent focus on PRO use to improve health care quality led to a National Institutes of Health sponsored initiative to develop a Patient-Reported Outcomes Measurement Information System (PROMIS). 4 The PROMIS measures apply item response theory (IRT) development to calibrate each individual item in such a way that computer algorithms can be applied to administer questions that omit or skip items depending on patient's prior answers. This computerized adaptive test (CAT) administration format minimizes respondent burden while maintaining desirable psychometric performance. 5 The useful measurement and administration qualities of the PROMIS Physical Function (PF) CAT have shown significant measurement efficiency 6, 7 particularly for lower extremity assessment of an orthopaedic population. 8 The use of IRT developed measures, like the PROMIS PF CAT, have been recommended for evaluating arthroplasty outcomes. 9 In the domain of joint function, several PROs have been developed. Though more than 75 PRO measures assess physical function, 10 the knee injury and osteoarthritis outcome score (KOOS) and hip and disability osteoarthritis score (HOOS) provide joint specific information and are now widely used assessments in joint replacement care. [11] [12] [13] [14] The HOOS and KOOS have recently been developed in short forms (HOOS JR and the KOOS JR) that ease respondent burden and are recognized in joint replacement registries as well as by CMS as approved PROs with sound psychometric properties. 2, [15] [16] [17] As the benefits of differing instruments are considered, understanding the responsiveness of an instrument, or in other words, the ability of an instrument to detect change over time 18 can assist clinicians in selecting appropriate PRO measures to enhance the quality of care. Both in evaluating the effectiveness of treatment options from a research perspective as well as an individual's response to treatment from a clinical perspective, information on the responsiveness of an instrument is important in selecting the best PROs to evaluate treatment outcomes.
In examining the responsiveness of outcome measures in a total knee arthroplasty population, it has been shown that patient response can differ substantially depending on which measure is used for assessment. 19 Both the HOOS JR and the KOOS JR have demonstrated high responsiveness levels in evaluating hip and knee arthroplasty, respectively. 16, 20 Some initial research measuring the responsiveness of the PROMIS PF CAT instrument in a rheumatoid arthritis patient population (N ¼ 451) has found that the PROMIS PF-20 (a 20-item test version) was able to detect a 1.2% difference compared to a 2.3% difference by a comparable legacy test. 21 Other research has also shown the PF-20 to be more responsive than legacy measures. 22 However, the PROMIS PF CAT has not been evaluated for responsiveness specifically with regards to an adult reconstruction patient population. When selecting an instrument to measure health changes, it is important to consider the responsiveness of the instruments. There have been no prior studies comparing the responsiveness of the PROMS PF CAT to the joint specific measures of the HOOS JR and KOOS JR. The purpose of the present study was to evaluate the responsiveness of the PROMIS PF CAT, the HOOS JR, and KOOS JR in a population of patients seen for varying joint conditions.
METHODS

Research Design
The research design is a Level 1 diagnostic study, testing a previously developed diagnostic measure on consecutive patients with the application of a reference standard. Responsiveness can be evaluated with internal methods which assess levels of change based on statistical distribution of data. The internal methods do not necessarily evaluate whether the change level is considered significant from a patient perspective. External methods of responsiveness link the measure of change to an external anchor, some other health measure that indicates a level of change that is considered meaningful from a patient perspective. 18 The comparison to an external anchor can utilize a gold standard treatment tool or a clinical measure that provides an a priori assessment of the patient's condition. 23 This study anchored change scores using an anchor question answered by the patients, "Compared to your FIRST EVALUATION at the University Orthopaedic Center: How would you describe your PHYSICAL FUNCTION LEVEL now?" Patients reporting no change were excluded from analysis, as is typical in responsiveness research. 24 Worsening symptomatology is associated with lower levels of change 25 and should be evaluated in terms of deterioration rather than change. 26 A number of prior studies have found PRO instruments to be differentially sensitive to improvement versus worsening [27] [28] [29] [30] and researchers have addressed this issue by evaluating positive change separately from negative change. 26, [31] [32] [33] [34] An insufficient analytical sample of less than 4.0% of patients reported worsening symptoms in the current sample, thus patients reporting worsening condition were excluded. Meaningful change was thus defined as a patient perceived improvement in condition in this study sample.
Sample Characteristics
The study sample consisted of 983 patients seen in an academic orthopaedic clinic between the years of 2014 and 2017. Patients were aged 18 years of age or older at the time of baseline assessment. Roughly 75% (737/983) of patients sought treatment for osteoarthritis. Additionally, 75 patients (7.6%) were treated for aseptic loosening of a prior joint replacement, 31 patients (3.2%) were treated for surgical site infections, 27 for congenital deformities (2.8%), 16 patients (1.6%) were treated for fracture, and the remaining 10% were treated for other causes. Seventy percent of the patients (692/983) underwent primary hip or knee arthroplasty. One hundred and sixty-four patients (17%) presented for revision hip or knee replacement. Five percent of patients (48/983) were treated conservatively. The remaining patients underwent hip preservation procedures (n ¼ 27), unicompartmental knee replacement (n ¼ 26), open reduction and internal fixation (n ¼ 13), irrigation and debridement (n ¼ 5), patellofemoroplasty (n ¼ 2), knee arthrodesis (n ¼ 2), girdlestone procedure (n ¼ 2), and above the knee amputation (n ¼ 2). Patient reported outcome measures and demographic information were collected on hand-held tablet computers provided to patients at the time of a clinic visit and prior to seeing the medical personnel. The PRO measurement is included in the orthopaedic clinic standard of care, and only 1.5% of patients refused to complete the measures, allowing consecutive enrollment based on qualifying patient condition and treatment. Patient reports of the experience of change in function may differ depending on the time of the clinic visit, and the sample size in each follow-up evaluation of responsiveness varied based on the time of follow-up visits. Institutional review board approval was obtained prior to the start of data collection.
Outcome Measures
The PROMIS PF CAT v1.2 draws from a 121-item test bank and was administered in a CAT format through a web-based portal (see supplemental Appendix S1). The PF CAT includes items for the upper and lower extremity as well as axial, central, and daily living to incorporate assessment covering a wide range of functioning, 35 but with reduced respondent burden attributed to the CAT administration. The CAT item sequencing and selection utilize the default algorithms established by PROMIS developers. 36 PROMIS instruments have standardized scoring with higher scores representing higher levels of function, are set to a T-score scale with a mean of 50, and have a standard deviation of 10. 6 The HOOS is made up of 40 items, but the shortened HOOS JR format used by our study contains just six items from the domains of function and pain (see supplemental Appendix S2). 16 The HOOS JR has demonstrated psychometric properties similar to the full HOOS 37 and has been recommended by CMS and the American Association of Hip and Knee Surgeons. 38 The HOOS JR is scored on a 0-100 scale with higher numbers indicating higher function. The KOOS consists of 42 questions but the shortened KOOS JR used by our study improves respondent burden with just seven questions in the domains of function and pain (see supplemental Appendix S3). 17 The KOOS JR is an accepted CMS metric for the Comprehensive Care for Joint Replacement Model, 2 is scored on a 1-100 scale with higher numbers indicating higher levels of function.
Analytic Approach
Patient demographic characteristics were analyzed by age, gender, race, and ethnicity. Change scores were calculated as the absolute value difference between baseline score and follow-up scores. Three-month follow-up scores were calculated in two ranges, as 90 days plus or minus 10 days and as 90 days and beyond. Six-month follow-up scores were RESPONSIVENESS OF PROMIS, HOOS, KOOS calculated in two ranges, as 180 days plus or minus 10 days and as 180 days and beyond. Follow-up time-periods of 3-and 6-month were selected to correspond with commonly used follow-up periods in prior orthopaedic literature and clinical practice. [39] [40] [41] [42] [43] Three-and six-months and beyond follow-up periods were used in addition to these narrowly defined time-periods to broaden the catchment time-frame to include the full-range of patients seeking follow-up care, also seen in prior literature. [44] [45] [46] Paired sample t-tests evaluated the hypothesis that no change occurred between baseline and each follow-up time point. The significance level was set at 0.05, two sided.
A standardized measure of effect size was evaluated using Cohen's d. This measure accounts for the variability that exists in scores. 18 Cohen As a second assessment of effect size the standardized response mean (SRM) was calculated. The SRM removes the dependence on sample size from the equation and it is normalized by the standard deviation of change scores. 18 The SRM reflects individual changes in scores and was calculated as the mean difference between scores at baseline to followup, divided by the standard deviation of difference scores. SRM values can be interpreted as 0.20, 0.50, and 0.80 for small, medium, and large effect sizes respectively, in the same fashion as interpreting Cohen's d. 18 Analyses were performed using SPSS 24.0 (IBM SPSS Statistics for Windows, Armonk, NY: IBM Corp.), 47 and R 3.30 (R Development Core Team, Vienna, AT: R Foundation for Statistical Computing).
48
RESULTS
There were a total of 983 patients with an average age of 61.03 years (SD ¼ 12.33, Range ¼ 18-90 years). Most of the patients were White (n ¼ 875, 89.0%). See Table 1 for full information on demographics.
Descriptive statistics of the PF CAT, HOOS JR, and KOOS JR are displayed in Table 2 . Not all patients returned to visit at every single time point; therefore, the sample size was different at different follow-up time points. Additionally, the sample sizes for the HOOS JR and the KOOS JR were substantially lower than the sample size for the PROMIS PF. This occurred because data collection on the HOOS JR and KOOS JR began in 2016 and also because the PROMIS PF was administered to all patients while the HOOS JR was only administered to patients with hips concerns, and KOOS JR to patients with knees concerns.
Paired-Samples t-Test
Responsiveness values are displayed in Table 3 . All instrument changes from baseline scores were significant at the 3-, >3-, and >6-month follow-up (p < 0.05).
However, at the 6-month follow-up, all instruments showed non-significant changes but the significance needs to be interpreted with caution due to small sample size for the 6-month follow-ups.
Effect Size
For the four different follow-up periods, the PF CAT, HOOS JR, and KOOS JR presented large effect sizes ranging from 0.80-1.20. The PF CAT consistently had the highest effect size for all four follow-up periods and displayed the largest effect size at the 6-month follow-up period (1.20). The HOOS JR had a large effect size overall but had the lowest effect size during the 3-month follow-up (0.80), 6-month follow-up (1.10), and >6-month follow-up (0.81). Similarly, the KOOS JR showed high effect size but was the lowest at the >3-month follow-up (0.85).
Standardized Response Mean
Responsiveness was also high for all three instruments when examining SRM (1.06-1.53). The PF CAT had the largest SRM during the 3-month follow-up (1.53) but also displayed larger SRM compared to the other measures at the >6-month follow-up (1.16). The HOOS JR showed the largest SRM at the >3-month follow-up (1.48) and >6-month follow-up, but was the lowest at the 3-month (1.19) and 6-month (1.06) follow-up period. The KOOS JR overall had high SRM, especially during the 6-month follow-up (1.47) but also displayed lower SRM during the >3-month follow-up (1.18) compared to the other measures.
DISCUSSION
Our study highlights the responsiveness of the PROMIS PF CAT compared to other legacy instruments such as the HOOS JR and KOOS JR among patients with joint reconstruction of the hip or knee. PROMIS instruments are NIH sponsored high-quality PROs with CAT administration that eases patient burden. 4 The recently developed short forms of the HOOS and KOOS provide important PRO information while easing respondent burden as well, and are approved CMS evaluations for the comprehensive care joint replacement model. 2, [15] [16] [17] Evaluating the responsiveness of these instruments is an important step in validating their use for clinical and research purposes.
Results from our study support past literature showing the PROMIS PF CAT to be a highly responsive instrument. 21, 22 At the four different follow-up periods, the PROMIS PF CAT demonstrated high responsiveness to change with large effect size and SRM for patients with joint arthroplasty. When examining effect size, the PF CAT was also consistently more responsive compared to the HOOS JR and KOOS JR although both HOOS JR and KOOS JR were also highly responsive. The PF CAT, HOOS JR, and KOOS JR all detected meaningful changes at all follow-up periods examined with each instrument possessing values that meet the cut-off for high responsiveness. When utilizing the effect size method, a value of 0.80 can be interpreted as high responsiveness, and was present for all instruments at the follow-up periods analyzed. All instruments also had high SRM at four different follow-up periods, with values greater than 1.0. It is important to analyze responsiveness with multiple methods as any one method may have strengths and weaknesses. We used the t-test in our study to detect significant score changes, which is dependent upon sample size. The effect size accounts for variability in scores and the SRM removes dependence on sample size constraints. These methods provide triangulation for looking at change scores through different lenses and consistently demonstrated the PF CAT, HOOS JR, and KOOS JR to be responsive to detecting change in the adult reconstruction patient population. This study's potential limitation is that all patients being seen for hip or knee reconstruction were grouped together when evaluating the responsiveness to change of the selected measures. From our limited sample size, we could not stratify different types of patients and examine their responsiveness to change based on their specific procedure code. Patients could have been seen for varying types of diagnoses which may exhibit varying levels of responsiveness to change. We also had insufficient sample size to evaluate the responsiveness of these instruments for those with worsening symptoms. Ongoing data collection will allow us to obtain more follow-up data on specific types of patient populations for future studies examining responsiveness. Further, none of the instruments at the greater than 6-month follow-up period showed significant changes in scores. This finding is likely a result of an insufficient sample size to detect a significance as t-tests are influenced by sample size. Data collection on the HOOS JR and KOOS JR was lower than for PROMIS instruments, partially due to the condition specific nature of the HOOS and KOOS as well as clinic constraints on instrument selection and implementation. Future research can continue this focus on cross-validating newer instruments with previously used measures. Future studies using bootstrapping may be warranted to examine whether the differences in responsiveness between the different measures are compatible with chance fluctuations.
As healthcare begins to ask more questions of our patients across all specialties of care, we are in danger of overburdening both our patients and staff with questionnaires. 49, 50 Efforts to reduce survey burden in the adult reconstruction arena have included the recent development of short form versions of the HOOS and KOOS legacy scores specific to joint reconstruction patients. 16, 17 Though both instruments (HOOS JR and KOOS JR) have demonstrated high responsiveness, 16, 17 we were also able to identify improved responsiveness with the PROMIS PF CAT. These findings are consistent with a previous report in the foot and ankle population when comparing the PF CAT to the Foot and Ankle Ability Measure-activity of daily living and the Foot Function Index 5-point verbal rating scale. 51 The results of these studies represent a novel finding, as the data have shown that a non-joint specific physical function survey can show high responsiveness to the intervention of multiple lower extremity procedures, including joint replacement of the hip and knee. This study represents an important step forward in our understanding of the use of PROs in adult reconstruction patients. With this work, along with other similar studies in lower extremity populations, 51, 52 it is plausible that we may find a way of incorporating advanced PRO tools, using CAT, that are also more generalized and still quite sensitive and responsive to patients undergoing very specific interventions. Thus, the use of a different survey for every different joint or surgical intervention in the human body may become obsolete as we begin to move forward with more globalized, low burden, but highly responsive questionnaires that could be used across multiple medical subspecialties and patient types.
Traditionally, PROs in the adult reconstruction arena have included the selection of at least two separate instruments, one to evaluate the general health of the patient and another to evaluate the joint specific outcomes. 53 Given the vast amounts of PROs available for not only evaluating all lower extremity joints, including the hip and knee, it has not only been difficult to make comparisons between published studies, but also within and between institutions who use separate measures. Given this, CMS reviewed multiple PROs for use in quality measures for TJA and determined that the measures should be completely patient derived and non-proprietary. 54 Ultimately, they selected the HOOS JR and the KOOS JR for joint specific measures, and either the Veterans Rand-12 item health survey or the PROMIS 10 global health assessment for general health. 54, 55 Though the HOOS JR and KOOS JR have demonstrated high responsiveness, joint specific measures lack the ability to compare to overall physical function. Joint specific measures have the advantage of face validity, while overall physical function measures can be used across fields to allow ease in comparing results across studiers. The PROMIS PF CAT is a measure of overall physical function and has demonstrated high responsiveness in several lower extremity populations. The future direction of PROs and CATs may allow us to utilize a single instrument for assessing function across multiple specialties.
This study demonstrated the responsiveness of the HOOS JR, KOOS JR, and the PROMIS PF in adult reconstruction patients. The PROMIS PF was consistently the most responsive instrument in this study. Overall, the PROMIS PF CAT, HOOS JR, and KOOS JR all demonstrated high responsiveness to change at four different follow-up periods (3-, >3-, 6-, and >6-month) among adult reconstruction patients. Using different analytical approaches, we were able to calculate different responsiveness indices for each instrument.
Our findings support other studies demonstrating high responsiveness of the PF CAT alongside other legacy instruments. 51 The HOOS JR, KOOS JR, and PROMIS PF are useful clinical instruments for assessing treatment change and may be selected as relevant to the specific needs and conditions of the adult joint reconstruction patient population. These findings should be used in conjunction with other responsiveness literature in order for researchers and clinicians to make informed decisions through enhanced interpretation and knowledge of these outcome measures. 
